This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Swine Respiratory Diseases Treatment Market

Market Insights on Swine Respiratory Diseases Treatment covering sales outlook, demand forecast & up-to-date key trends

Swine Respiratory Diseases Treatment Market By Causative Agent (Virus, Mycoplasma, Bacteria), Treatment Type (Drugs, Vaccines), Route of Administration (Oral, Parenteral), Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies) & Region - Forecast 2017 - 2027

Increase in pork consumption across various regions to help lift the global swine respiratory diseases treatment market in the coming decade

The market for Swine Respiratory Diseases Treatment witnessed a massive slowdown in its progress as a result of the spread of Covid-19 pandemic across the globe. But in the post covid world, the increasing demand for pork by the people who are home-bound directly boosts the pork industry to produce more pork that is disease free, to enable the pork industry to meet the increasing demand for pork in the global market. As recovery commences in 2021, major players are recuperating their positions through production expansion, capacity utilizations and online selling in 2021 keeping in view the covid-19 norms.

Leading companies such as Boehringer Ingelheim Vetmedica Inc., Norbrook, Ceva Santé Animale, Zoetis Inc., Agrilabs Inc., Thermo Fisher Scientific Inc, Vetoquinol, Bimeda holdings PLC, Bayer AG, Elanco Animal Health, Virbac Group and Merck Animal Health are actively indulged in the adoption of several market strategies like joint ventures, collaborations, partnership agreements, technological advancements, sales agreements, capacity utilizations, innovations, diversifications, geographical expansions etc to ensure improvements in their operations globally.

For instance, In March 2021, Zoetis Inc. announced its campaign named “Driven to Care”, aiming towards its long term sustainability goals to nurture the world and humankind by advancing care for animals. With “Driven to Care”, Zoetis commits to communities, animals and the planet with support from 10 of the 17 United Nations’ Sustainable Development Goals (SDGs).

In addition to this,  Norbrook, in partnership with Invest NI, recently announced the completion of the order of its new formulations laboratory to be operational with the  highest Good Laboratory Practices (GLP) standards. This is projected to support Norbrook in reaching the global markets and giving rise to new products in the coming years. The company is continuing investment in innovation and Research and Development to be a top global provider of veterinary pharmaceuticals focusing immensely on the health of the farms and animals. In terms of growth, the North America region is projected to dominate the market with a very high revenue rate during the forecast period. The other key regions augmenting the growth of the Swine Respiratory Diseases Treatment market are Asia Pacific excluding Japan, Europe, Latin America and MEA.

Pigs are mostly affected with respiratory diseases such as PRRS (Porcine Reproductive and Respiratory Syndrome), which is a one of the common diseases. The Porcine Respiratory and Reproductive Syndrome is caused by a virus and is categorised under arterivirus. PRRS disease is also known as blue-ear pig disease. The PRRS was identified in USA during the 1980’s and is also known as the mystery swine disease.

The PRRS disease is rapidly spreading in all the countries that are into pig productions, very few countries are left which are PRRS free today. The consumption of pork is increasing over the years across all the regions, which directly boosts the pork industry to produce more pork that is disease free, to enable the pork industry to meet the increasing demand for pork in the global market.

Customize this Report

Let us know your requirement to get
100% FREE customization

Market snapshot of the top regions in the global swine respiratory diseases treatment market

APEJ: APEJ is expected to lead the global swine respiratory diseases treatment market with its market size reaching a value of over US$ 1,100 Mn in 2027, growing at a CAGR 6.7%. However it is in close competition with Eastern Europe, which is leading in terms of CAGR, with a robust market growth at 6.9% CAGR during the forecast period. The animal industry is one of the fastest growing sectors in most countries of the Asia Pacific region. It is a vital industry linked to millions of jobs in related industries.

However, the health and growth of this industry are being threatened by the emergence of animal diseases. APEJ’s market includes China’s pig industry, where the Chinese government is willing to invest and increase the pig industry by implementing supporting policies to support large pig farmers.

Chinese scholars have indicated that they have found a new strain of PRRS virus (PRRSV) GDsg that was isolated in the Guangdong province of China, which caused high fever, high morbidity and high mortality for sow and piglets. This is helping APEJ’s swine respiratory diseases treatment market to grow exceptionally.

North America: The demand of pork in countries such as US and Canada is increasing, as a result the production of pork is increasing to meet the needs of the market. The pathogen free pork is directly contributing to the demand of the meat industry. In the pork industry in North America, especially in the U.S, most of the pork farms are using vaccines as the pork industry is looking forward to produce pork which is disease free. Vaccines are mostly used as preventive process to overcome the harmful pathogens.

Swine Respiratory Diseases Treatment Market Download Report Brochure

The use of vaccines for PRRS (porcine reproductive and respiratory syndrome) and mycoplasma is increasing, the vaccine is directly given to breeding females, to enable the new born pig to be pathogen free. The increase in use of vaccines has helped North America’s market to reach a size of over US$ 780 Mn in 2027, growing at a CAGR of 6.5% during the forecast period. Also, the market is quite positive for investors in the animal healthcare sector and it seems like a win-win situation for both the parties (investors and manufacturers) in the long term.

Segmentation of the Global Swine Respiratory Diseases Treatment Market

The segmentation of the global swine respiratory diseases treatment market helps readers simplify the market study and understanding, by dividing the market into different segments on the basis of various parameters. The report provides an individual analysis of each and every segment, thus covering every part of the market.

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • MEA

By Causative Agent:

  • Virus
  • Mycoplasma
  • Bacteria
  • Others

By Treatment Type:

  • Drugs
    • Antibiotic
    • Others
  • Vaccines

By Route of Administration:

  • Oral
  • Parenteral

By Distribution Channel:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies
  • Others
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Frequently Asked Questions

The swine respiratory diseases treatment market is likely to record a CAGR of 6.75% through 2032.

Sales of swine respiratory diseases treatment are likely to exceed a valuation of US$ 1525 Mn by 2032.

The swine respiratory diseases treatment market share is likely to grow by over US$ 1100 Mn in 2022.

Asia Pacific is likely to witness the highest growth in the swine respiratory diseases treatment market.

Table of Content

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Swine Respiratory Treatment Market View Point

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

3.3. Swine respiratory diseases cause agent and effects

3.4. Regulatory Scenario

4. North America Swine Respiratory Treatment Market Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Regional Market Dynamics

4.2.1.cDrivers

4.2.2. Restraints

4.2.3. Trends

4.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

4.3.1. U.S.

4.3.2. Canada

4.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

4.4.1. U.S.

4.4.2. Canada

4.5. Historical Market Size (US$ Mn) Analysis By Causative Agent, 2012-2016

4.5.1. Virus

4.5.2. Mycoplasma

4.5.3. Bacteria

4.5.4. Others

4.6. Market Size (US$ Mn) Forecast By Causative Agent, 2017-2027

4.6.1. Virus

4.6.2. Mycoplasma

4.6.3. Bacteria

4.6.4. Others

4.7. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2012-2016

4.7.1. Drugs

4.7.1.1. Antibiotics

4.7.1.2. Others

4.7.2. Vaccines 

4.8. Market Size (US$ Mn) Forecast By Treatment Type, 2017-2027

4.8.1. Drugs

4.8.1.1. Antibiotics

4.8.1.2. Others

4.8.2. Vaccines 

4.9. Historical Market Size (US$ Mn) Analysis By Route of Administration Type, 2012-2016

4.9.1. Oral

4.9.2. Parenteral

4.10.Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

4.10.1. Oral

4.10.2. Parenteral

4.11.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

4.11.1. Veterinary Hospitals

4.11.2. Veterinary Clinics

4.11.3. Pharmacies

4.11.4. Others

4.12.Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

4.12.1. Veterinary Hospitals

4.12.2. Veterinary Clinics

4.12.3. Pharmacies

4.12.4. Others

4.13.Drivers and Restraints: Impact Analysis

4.14.Market Attractiveness Analysis

4.14.1. By Country

4.14.2. By Causative Agent

4.14.3. By Treatment Type

4.14.4. By Route of Administration

4.14.5. By Distribution Channel

4.15.Key Representative Market Participants

4.16.Key Participants Market Presence (Intensity Map)

5. Latin America Swine Respiratory Treatment Market Analysis 2012–2016 and Forecast 2017–2027

5.1. Introduction

5.2. Regional Market Dynamics

5.2.1. Drivers

5.2.2. Restraints

5.2.3. Trends

5.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

5.3.1. Brazil

5.3.2. Mexico

5.3.3. Rest of Latin America

5.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

5.4.1. Brazil

5.4.2. Mexico

5.4.3. Rest of Latin America

5.5. Historical Market Size (US$ Mn) Analysis By Causative Agent, 2012-2016

5.5.1. Virus

5.5.2. Mycoplasma

5.5.3. Bacteria

5.5.4. Others

5.6. Market Size (US$ Mn) Forecast By Causative Agent, 2017-2027

5.6.1. Virus

5.6.2. Mycoplasma

5.6.3. Bacteria

5.6.4. Others

5.7. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2012-2016

5.7.1. Drugs

5.7.1.1. Antibiotics

5.7.1.2. Others

5.7.2. Vaccines 

5.8. Market Size (US$ Mn) Forecast By Treatment Type, 2017-2027

5.8.1. Drugs

5.8.1.1. Antibiotics

5.8.1.2. Others

5.8.2. Vaccines 

5.9. Historical Market Size (US$ Mn) Analysis By Route of Administration Type, 2012-2016

5.9.1. Oral

5.9.2. Parenteral

5.10.Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

5.10.1. Oral

5.10.2. Parenteral

5.11.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

5.11.1. Veterinary Hospitals

5.11.2. Veterinary Clinics

5.11.3. Pharmacies

5.11.4. Others

5.12.Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

5.12.1. Veterinary Hospitals

5.12.2. Veterinary Clinics

5.12.3. Pharmacies

5.12.4. Others

5.13.Drivers and Restraints: Impact Analysis

5.14.Market Attractiveness Analysis

5.14.1. By Country

5.14.2. By Causative Agent

5.14.3. By Treatment Type

5.14.4. By Route of Administration

5.14.5. By Distribution Channel

5.15.Key Representative Market Participants

Key Participants Market Presence (Intensity Map)

6. Western Europe Swine Respiratory Treatment Market Analysis 2012–2016 and Forecast 2017–2027

6.1. Introduction

6.2. Regional Market Dynamics

6.2.1. Drivers

6.2.2. Restraints

6.2.3. Trends

6.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

6.3.1. Germany

6.3.2. UK

6.3.3. France

6.3.4. Spain

6.3.5. Italy

6.3.6. Nordic Countries

6.3.7. Rest of Western Europe

6.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

6.4.1. Germany

6.4.2. UK

6.4.3. France

6.4.4. Spain

6.4.5. Italy

6.4.6. Nordic Countries

6.4.7. Rest of Western Europe

6.5. Historical Market Size (US$ Mn) Analysis By Causative Agent, 2012-2016

6.5.1. Virus

6.5.2. Mycoplasma

6.5.3. Bacteria

6.5.4. Others

6.6. Market Size (US$ Mn) Forecast By Causative Agent, 2017-2027

6.6.1. Virus

6.6.2. Mycoplasma

6.6.3. Bacteria

6.6.4. Others

6.7. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2012-2016

6.7.1. Drugs

6.7.1.1. Antibiotics

6.7.1.2. Others

6.7.2. Vaccines 

6.8. Market Size (US$ Mn) Forecast By Treatment Type, 2017-2027

6.8.1. Drugs

6.8.1.1. Antibiotics

6.8.1.2. Others

6.8.2. Vaccines 

6.9. Historical Market Size (US$ Mn) Analysis By Route of Administration Type, 2012-2016

6.9.1. Oral

6.9.2. Parenteral

6.10.Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

6.10.1. Oral

6.10.2. Parenteral

6.11.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

6.11.1. Veterinary Hospitals

6.11.2. Veterinary Clinics

6.11.3. Pharmacies

6.11.4. Others

6.12.Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

6.12.1. Veterinary Hospitals

6.12.2. Veterinary Clinics

6.12.3. Pharmacies

6.12.4. Others

6.13.Drivers and Restraints: Impact Analysis

6.14.Market Attractiveness Analysis

6.14.1. By Country

6.14.2. By Causative Agent

6.14.3. By Treatment Type

6.14.4. By Route of Administration

6.14.5. By Distribution Channel

6.15.Key Representative Market Participants

6.16.Key Participants Market Presence (Intensity Map)

7. Eastern Europe Swine Respiratory Treatment Market Analysis 2012–2016 and Forecast 2017–2027

7.1. Introduction

7.2. Regional Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Trends

7.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

7.3.1. Russia

7.3.2. Poland

7.3.3. Rest of Eastern Europe

7.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

7.4.1. Russia

7.4.2. Poland

7.4.3. Rest of Eastern Europe

7.5. Historical Market Size (US$ Mn) Analysis By Causative Agent, 2012-2016

7.5.1. Virus

7.5.2. Mycoplasma

7.5.3. Bacteria

7.5.4. Others

7.6. Market Size (US$ Mn) Forecast By Causative Agent, 2017-2027

7.6.1. Virus

7.6.2. Mycoplasma

7.6.3. Bacteria

7.6.4. Others

7.7. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2012-2016

7.7.1. Drugs

7.7.1.1. Antibiotics

7.7.1.2. Others

7.7.2. Vaccines 

7.8. Market Size (US$ Mn) Forecast By Treatment Type, 2017-2027

7.8.1. Drugs

7.8.1.1. Antibiotics

7.8.1.2. Others

7.8.2. Vaccines 

7.9. Historical Market Size (US$ Mn) Analysis By Route of Administration Type, 2012-2016

7.9.1. Oral

7.9.2. Parenteral

7.10.Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

7.10.1. Oral

7.10.2. Parenteral

7.11.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

7.11.1. Veterinary Hospitals

7.11.2. Veterinary Clinics

7.11.3. Pharmacies

7.11.4. Others

7.12.Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

7.12.1. Veterinary Hospitals

7.12.2. Veterinary Clinics

7.12.3. Pharmacies

7.12.4. Others

7.13.Drivers and Restraints: Impact Analysis

7.14.Market Attractiveness Analysis

7.14.1. By Country

7.14.2. By Causative Agent

7.14.3. By Treatment Type

7.14.4. By Route of Administration

7.14.5. By Distribution Channel

7.15.Key Representative Market Participants

7.16.Key Participants Market Presence (Intensity Map)

8. Asia Pacific Excluding Japan Swine Respiratory Treatment Market Analysis 2012–2016 and Forecast 2017–2027

8.1. Introduction

8.2. Regional Market Dynamics

8.2.1. Drivers

8.2.2. Restraints

8.2.3. Trends

8.3. Historical Market Size (US$ Mn) and Analysis By Country, 2012-2016

8.3.1. China

8.3.2. Philippine

8.3.3. South Korea

8.3.4. India

8.3.5. Australia

8.3.6. Rest of Asia Pacifc

8.4. Market Size (US$ Mn) and Forecast By Country, 2017-2027

8.4.1. China

8.4.2. Philippine

8.4.3. South Korea

8.4.4. India

8.4.5. Australia

8.4.6. Rest of Asia Pacifc

8.5. Historical Market Size (US$ Mn) Analysis By Causative Agent, 2012-2016

8.5.1. Virus

8.5.2. Mycoplasma

8.5.3. Bacteria

8.5.4. Others

8.6. Market Size (US$ Mn) Forecast By Causative Agent, 2017-2027

8.6.1. Virus

8.6.2. Mycoplasma

8.6.3. Bacteria

8.6.4. Others

8.7. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2012-2016

8.7.1. Drugs

8.7.1.1. Antibiotics

8.7.1.2. Others

8.7.2. Vaccines 

8.8. Market Size (US$ Mn) Forecast By Treatment Type, 2017-2027

8.8.1. Drugs

8.8.1.1. Antibiotics

8.8.1.2. Others

8.8.2. Vaccines 

8.9. Historical Market Size (US$ Mn) Analysis By Route of Administration Type, 2012-2016

8.9.1. Oral

8.9.2. Parenteral

8.10.Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

8.10.1. Oral

8.10.2. Parenteral

8.11.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

8.11.1. Veterinary Hospitals

8.11.2. Veterinary Clinics

8.11.3. Pharmacies

8.11.4. Others

8.12.Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

8.12.1. Veterinary Hospitals

8.12.2. Veterinary Clinics

8.12.3. Pharmacies

8.12.4. Others

8.13.Drivers and Restraints: Impact Analysis

8.14.Market Attractiveness Analysis

8.14.1. By Country

8.14.2. By Causative Agent

8.14.3. By Treatment Type

8.14.4. By Route of Administration

8.14.5. By Distribution Channel

8.15.Key Representative Market Participants

8.16.Key Participants Market Presence (Intensity Map)

9. Japan Swine Respiratory Treatment Market Analysis 2012–2016 and Forecast 2017–2027

9.1. Introduction

9.2. Japan Market Dynamics

9.2.1. Drivers

9.2.2. Restraints

9.2.3. Trends

9.3. Historical Market Size (US$ Mn) Analysis By Causative Agent, 2012-2016

9.3.1. Virus

9.3.2. Mycoplasma

9.3.3. Bacteria

9.3.4. Others

9.4. Market Size (US$ Mn) Forecast By Causative Agent, 2017-2027

9.4.1. Virus

9.4.2. Mycoplasma

9.4.3. Bacteria

9.4.4. Others

9.5. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2012-2016

9.5.1. Drugs

9.5.1.1. Antibiotics

9.5.1.2. Others

9.5.2. Vaccines 

9.6. Market Size (US$ Mn) Forecast By Treatment Type, 2017-2027

9.6.1. Drugs

9.6.1.1. Antibiotics

9.6.1.2. Others

9.6.2. Vaccines 

9.7. Historical Market Size (US$ Mn) Analysis By Route of Administration Type, 2012-2016

9.7.1. Oral

9.7.2. Parenteral

9.8. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

9.8.1. Oral

9.8.2. Parenteral

9.9. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

9.9.1. Veterinary Hospitals

9.9.2. Veterinary Clinics

9.9.3. Pharmacies

9.9.4. Others

9.10.Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

9.10.1. Veterinary Hospitals

9.10.2. Veterinary Clinics

9.10.3. Pharmacies

9.10.4. Others

9.11.Drivers and Restraints: Impact Analysis

9.12.Market Attractiveness Analysis

9.12.1. By Causative Agent

9.12.2. By Treatment Type

9.12.3. By Route of Administration

9.12.4. By Distribution Channel

9.13.Key Representative Market Participants

9.14.Key Participants Market Presence (Intensity Map)

10. Middle East and Africa Swine Respiratory Treatment Market Analysis 2012–2016 and Forecast 2017–2027

10.1.Introduction

10.2.Regional Market Dynamics

10.2.1. Drivers

10.2.2. Restraints

10.2.3. Trends

10.3.Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

10.3.1. GCC Countries

10.3.2. South Africa

10.3.3. Rest of Middle East and Africa

10.4.Market Size (US$ Mn) Forecast By Country, 2017-2027

10.4.1. GCC Countries

10.4.2. South Africa

10.4.3. Rest of Middle East and Africa

10.5.Historical Market Size (US$ Mn) Analysis By Causative Agent, 2012-2016

10.5.1. Virus

10.5.2. Mycoplasma

10.5.3. Bacteria

10.5.4. Others

10.6.Market Size (US$ Mn) Forecast By Causative Agent, 2017-2027

10.6.1. Virus

10.6.2. Mycoplasma

10.6.3. Bacteria

10.6.4. Others

10.7.Historical Market Size (US$ Mn) Analysis By Treatment Type, 2012-2016

10.7.1. Drugs

10.7.1.1. Antibiotics

10.7.1.2. Others

10.7.2. Vaccines 

10.8.Market Size (US$ Mn) Forecast By Treatment Type, 2017-2027

10.8.1. Drugs

10.8.1.1. Antibiotics

10.8.1.2. Others

10.8.2. Vaccines 

10.9.Historical Market Size (US$ Mn) Analysis By Route of Administration Type, 2012-2016

10.9.1. Oral

10.9.2. Parenteral

10.10. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

10.10.1. Oral

10.10.2. Parenteral

10.11. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

10.11.1. Veterinary Hospitals

10.11.2. Veterinary Clinics

10.11.3. Pharmacies

10.11.4. Others

10.12. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

10.12.1. Veterinary Hospitals

10.12.2. Veterinary Clinics

10.12.3. Pharmacies

10.12.4. Others

10.13. Drivers and Restraints: Impact Analysis

10.14. Market Attractiveness Analysis

10.14.1. By Country

10.14.2. By Causative Agent

10.14.3. By Treatment Type

10.14.4. By Route of Administration

10.14.5. By Distribution Channel

10.15. Key Representative Market Participants

10.16. Key Participants Market Presence (Intensity Map)

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Competition Landscape

13.1.Competition Dashboard

13.2.Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

13.2.1. Zoetis

13.2.2. Bayer AG

13.2.3. Boehringer Ingelheim GmbH

13.2.4. Elanco Animal Health (Sub. Eli Lilly)

13.2.5. Virbac

13.2.6. Norbrook

13.2.7. Ceva Santé Animale

13.2.8. Intervet Inc., (Sub. Merck & Co. Inc.) 

13.2.9. Vetoquinol SA

13.2.10. Bimeda, Inc.

13.2.11. Kyoritsu Seiyaku Corporation

13.2.12. HIPRA

14. Global Swine Respiratory Treatment Market Analysis 2012–2016 and Forecast 2017–2027 By Region

14.1.Introduction / Key Findings

14.2.Historical Market Size (US$ Mn) Analysis By Region

14.2.1. North America

14.2.2. Latin America

14.2.3. Western Europe

14.2.4. Eastern Europe

14.2.5. Asia Pacific Excluding Japan

14.2.6. Japan

14.2.7. Middle East and Africa

14.3.Market Size (US$ Mn) Forecast By Region

14.3.1. North America

14.3.2. Latin America

14.3.3. Western Europe

14.3.4. Eastern Europe

14.3.5. Asia Pacific Excluding Japan

14.3.6. Japan

14.3.7. Middle East and Africa

14.4.Market Attractiveness Analysis By Region

15. Global Swine Respiratory Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Causative Agent

15.1.Introduction/Key Finding

15.2.Historical Market Size (US$ Mn) Analysis By Causative Agent, 2012-2016

15.2.1. Virus

15.2.2. Mycoplasma

15.2.3. Bacteria

15.2.4. Others

15.3.Market Size (US$ Mn) Forecast By Causative Agent, 2017-2027

15.3.1. Virus

15.3.2. Mycoplasma

15.3.3. Bacteria

15.3.4. Others

15.4.Market Attractiveness Analysis By Causative Agent

16. Global Swine Respiratory Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Treatment Type

16.1.Introduction/Key Finding

16.2.Historical Market Size (US$ Mn) Analysis By Treatment Type, 2012-2016

16.2.1. Drugs

16.2.1.1. Antibiotics

16.2.1.2. Others

16.2.2. Vaccines 

16.3.Market Size (US$ Mn) Forecast By Treatment Type, 2017-2027

16.3.1. Drugs

16.3.1.1. Antibiotics

16.3.1.2. Others

16.3.2. Vaccines 

16.4.Market Attractiveness Analysis By Treatment Type

17. Global Swine Respiratory Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Route of Administration

17.1.Introduction/Key Finding

17.2.Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016

17.2.1. Oral

17.2.2. Parenteral

17.3.Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

17.3.1. Oral

17.3.2. Parenteral

17.4.Market Attractiveness Analysis By Route of Administration

18. Global Swine Respiratory Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Distribution Channel

18.1.Introduction/Key Finding

18.2.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

18.2.1. Veterinary Hospitals

18.2.2. Veterinary Clinics

18.2.3. Pharmacies

18.2.4. Others

18.3.Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

18.3.1. Veterinary Hospitals

18.3.2. Veterinary Clinics

18.3.3. Pharmacies

18.3.4. Others

18.4.Market Attractiveness Analysis By Distribution Channel

19. Global Swine Respiratory Treatment Market Analysis 2012–2016 and Forecast 2017–2027

19.1.Market Size and Y-o-Y Growth

19.2.Absolute $ Opportunity

19.3.Value Chain

20. Assumptions and Acronyms Used

21. Research Methodology 

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 02 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Causative Agent Segment

Table 03 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Treatment Type Segment

Table 04 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration Segment

Table 05: North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel Segment

Table 06 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 07 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Causative Agent Segment

Table 08 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Treatment Type Segment

Table 09 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration Segment

Table 10 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel Segment

Table 11 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 12 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Causative Agent Segment

Table 13 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Treatment Type Segment

Table 14 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration Segment

Table 15 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel Segment

Table 16 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 17 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Causative Agent Segment

Table 18 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Treatment Type Segment

Table 19 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration Segment

Table 20 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel Segment

Table 21 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, by Country

Table 22 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Causative Agent Segment

Table 23 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Treatment Type Segment

Table 24 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration Segment

Table 25 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel Segment

Table 26 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Causative Agent Segment

Table 27 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Treatment Type Segment

Table 28 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration Segment

Table 29 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel Segment

Table 30 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 31 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Causative Agent Segment

Table 32 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Treatment Type Segment

Table 33 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration Segment

Table 34 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel Segment

Table 35 : Global Swine Respiratory Diseases Treatment Market Size (US$ Mn) Forecast by Region, 2012–2017

Table 36 : Global Swine Respiratory Diseases Treatment Market Size (US$ Mn) Forecast By Causative Agent, 2012–2017

Table 37 : Global Swine Respiratory Diseases Treatment Market Size (US$ Mn) Forecast By Treatment Type, 2012–2017

Table 38 : Global Swine Respiratory Diseases Treatment Market Size (US$ Mn) Forecast by Route of Administration, 2012–2017

Table 39 : Global Swine Respiratory Diseases Treatment Market Size (US$ Mn) Forecast by Distribution Channel, 2012–2017

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 01 : North America Swine Respiratory Diseases Treatment Market Value Share By Causative Agent (2017)

Figure 02 : North America Swine Respiratory Diseases Treatment Market Value Share By Treatment Type (2017)

Figure 03 : North America Swine Respiratory Diseases Treatment Market Value Share By Route of Administration (2017)

Figure 04 : North America Swine Respiratory Diseases Treatment Market Value Share By Distribution Channel (2017)

Figure 05 : North America Swine Respiratory Diseases Treatment Market Forecast 2017 and 2027

Figure 06 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 07 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 08 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Virus Segment

Figure 09 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Virus Segment

Figure 10 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Segment

Figure 11 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Segment

Figure 12 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Bacteria Segment

Figure 13 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Bacteria Segment

Figure 14 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Others Segment

Figure 15 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others Segment

Figure 16 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Drugs  Segment

Figure 17 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Drugs  Segment

Figure 18 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Vaccines Segment

Figure 19 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vaccines Segment

Figure 20 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Oral Segment

Figure 21 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Oral Segment

Figure 22 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Parenteral Segment

Figure 23 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Parenteral Segment

Figure 24 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Veterinary Hospitals Segment

Figure 25 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Veterinary Hospitals Segment

Figure 26 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Veterinary Clinics Segment

Figure 27 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Veterinary Clinics Segment

Figure 28 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Pharmacies Segment

Figure 29 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Pharmacies Segment

Figure 30 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Others Segment

Figure 31 : North America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others Segment

Figure 32 : North America Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, By Causative Agent

Figure 33 : North America Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, By Treatment Type Type

Figure 34 : North America Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, by Route of Administration 

Figure 35 : North America Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, by Distribution Channel

Figure 36 : North America Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, by Country

Figure 37 : Latin America Swine Respiratory Diseases Treatment Market Value Share By Causative Agent (2017)

Figure 38 : Latin America Swine Respiratory Diseases Treatment Market Value Share By Treatment Type (2017)

Figure 39 : Latin America Swine Respiratory Diseases Treatment Market Value Share By Route of Administration (2017)

Figure 40 : Latin America Swine Respiratory Diseases Treatment Market Value Share By Distribution Channel (2017)

Figure 41 : Latin America Swine Respiratory Diseases Treatment Market Forecast 2017 and 2027

Figure 42 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 43 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 44 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Virus Segment

Figure 45 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Virus Segment

Figure 46 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Segment

Figure 47 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Segment

Figure 48 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Bacteria Segment

Figure 49 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Bacteria Segment

Figure 50 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Others Segment

Figure 51 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others Segment

Figure 52 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Drugs  Segment

Figure 53 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Drugs  Segment

Figure 54 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Vaccines Segment

Figure 55 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vaccines Segment

Figure 56 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Oral Segment

Figure 57 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Oral Segment

Figure 58 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Parenteral Segment

Figure 59 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Parenteral Segment

Figure 60 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Veterinary Hospitals Segment

Figure 61 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Veterinary Hospitals Segment

Figure 62 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Veterinary Clinics Segment

Figure 63 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Veterinary Clinics Segment

Figure 64 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Pharmacies Segment

Figure 65 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Pharmacies Segment

Figure 66 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Others Segment

Figure 67 : Latin America Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others Segment

Figure 68 : Latin America Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, By Causative Agent

Figure 69 : Latin America Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, By Treatment Type Type

Figure 70 : Latin America Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, by Route of Administration 

Figure 71 : Latin America Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, by Distribution Channel

Figure 72 : Latin America Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, by Country

Figure 73 : Western Europe Swine Respiratory Diseases Treatment Market Value Share By Causative Agent (2017)

Figure 74 : Western Europe Swine Respiratory Diseases Treatment Market Value Share By Treatment Type (2017)

Figure 75 : Western Europe Swine Respiratory Diseases Treatment Market Value Share By Route of Administration (2017)

Figure 76 : Western Europe Swine Respiratory Diseases Treatment Market Value Share By Distribution Channel (2017)

Figure 77 : Western Europe Swine Respiratory Diseases Treatment Market Forecast 2017 and 2027

Figure 78 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 79 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 80 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Virus Segment

Figure 81 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Virus Segment

Figure 82 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Segment

Figure 83 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Segment

Figure 84 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Bacteria Segment

Figure 85 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Bacteria Segment

Figure 86 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Others Segment

Figure 87 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others Segment

Figure 88 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Drugs  Segment

Figure 89 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Drugs  Segment

Figure 90 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Vaccines Segment

Figure 91 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vaccines Segment

Figure 92 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Oral Segment

Figure 93 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Oral Segment

Figure 94 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Parenteral Segment

Figure 95 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Parenteral Segment

Figure 96 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Veterinary Hospitals Segment

Figure 97 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Veterinary Hospitals Segment

Figure 98 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Veterinary Clinics Segment

Figure 99 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Veterinary Clinics Segment

Figure 100 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Pharmacies Segment

Figure 101 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Pharmacies Segment

Figure 102 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Others Segment

Figure 103 : Western Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others Segment

Figure 104 : Western Europe Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, By Causative Agent

Figure 105 : Western Europe Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, By Treatment Type Type

Figure 106 : Western Europe Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, by Route of Administration 

Figure 107 : Western Europe Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, by Distribution Channel

Figure 108 : Western Europe Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, by Country

Figure 109 : Eastern Europe Swine Respiratory Diseases Treatment Market Value Share By Causative Agent (2017)

Figure 110 : Eastern Europe Swine Respiratory Diseases Treatment Market Value Share By Treatment Type (2017)

Figure 111 : Eastern Europe Swine Respiratory Diseases Treatment Market Value Share By Route of Administration (2017)

Figure 112 : Eastern Europe Swine Respiratory Diseases Treatment Market Value Share By Distribution Channel (2017)

Figure 113: Eastern Europe Swine Respiratory Diseases Treatment Market Forecast 2017 and 2027

Figure 114 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 115 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 116 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Virus Segment

Figure 117 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Virus Segment

Figure 118 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Segment

Figure 119 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Segment

Figure 120 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Bacteria Segment

Figure 121 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Bacteria Segment

Figure 122 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Others Segment

Figure 123 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others Segment

Figure 124 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Drugs  Segment

Figure 125 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Drugs  Segment

Figure 126 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Vaccines Segment

Figure 127 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vaccines Segment

Figure 128 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Oral Segment

Figure 129 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Oral Segment

Figure 130 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Parenteral Segment

Figure 131 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Parenteral Segment

Figure 132 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Veterinary Hospitals Segment

Figure 133 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Veterinary Hospitals Segment

Figure 134 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Veterinary Clinics Segment

Figure 135 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Veterinary Clinics Segment

Figure 136 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Pharmacies Segment

Figure 137 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Pharmacies Segment

Figure 138 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Others Segment

Figure 139 : Eastern Europe Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others Segment

Figure 140 : Eastern Europe Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, By Causative Agent

Figure 141 : Eastern Europe Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, By Treatment Type Type

Figure 142 : Eastern Europe Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, by Route of Administration 

Figure 143 : Eastern Europe Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, by Distribution Channel

Figure 144 : Eastern Europe Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, by Country

Figure 145 : APEJ Swine Respiratory Diseases Treatment Market Value Share By Causative Agent (2017)

Figure 146 : APEJ Swine Respiratory Diseases Treatment Market Value Share By Treatment Type (2017)

Figure 147 : APEJ Swine Respiratory Diseases Treatment Market Value Share By Route of Administration (2017)

Figure 148 : APEJ Swine Respiratory Diseases Treatment Market Value Share By Distribution Channel (2017)

Figure 149 : APEJ Swine Respiratory Diseases Treatment Market Forecast 2017 and 2027

Figure 150 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 151 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 152 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Virus Segment

Figure 153 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Virus Segment

Figure 154 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Segment

Figure 155: APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Segment

Figure 156 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Bacteria Segment

Figure 157 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Bacteria Segment

Figure 158 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Others Segment

Figure 159 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others Segment

Figure 160 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Drugs  Segment

Figure 161 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Drugs  Segment

Figure 162 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Vaccines Segment

Figure 163 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vaccines Segment

Figure 164 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Oral Segment

Figure 165 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Oral Segment

Figure 166 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Parenteral Segment

Figure 167 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Parenteral Segment

Figure 168 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Veterinary Hospitals Segment

Figure 169 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Veterinary Hospitals Segment

Figure 170 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Veterinary Clinics Segment

Figure171 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Veterinary Clinics Segment

Figure 172 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Pharmacies Segment

Figure 173 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Pharmacies Segment

Figure 174 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Others Segment

Figure 175 : APEJ Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others Segment

Figure 176 : APEJ Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, By Causative Agent

Figure 177 : APEJ Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, By Treatment Type Type

Figure 178 : APEJ Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, by Route of Administration 

Figure 179 : APEJ Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, by Distribution Channel

Figure 180 : APEJ Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, by Country

Figure 181 : Japan Swine Respiratory Diseases Treatment Market Value Share By Causative Agent (2017)

Figure 182 : Japan Swine Respiratory Diseases Treatment Market Value Share By Treatment Type (2017)

Figure 183 : Japan Swine Respiratory Diseases Treatment Market Value Share By Route of Administration (2017)

Figure 184 : Japan Swine Respiratory Diseases Treatment Market Value Share By Distribution Channel (2017)

Figure 185 : Japan Swine Respiratory Diseases Treatment Market Forecast 2017 and 2027

Figure 186 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 187 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 188 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Virus Segment

Figure 189 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Virus Segment

Figure 190 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Segment

Figure 191 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Segment

Figure 192 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Bacteria Segment

Figure 193 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Bacteria Segment

Figure 194 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Others Segment

Figure 195 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others Segment

Figure 196 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Drugs  Segment

Figure 197 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Drugs  Segment

Figure 198 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Vaccines Segment

Figure 199 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vaccines Segment

Figure 200 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Oral Segment

Figure 201 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Oral Segment

Figure 202 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Parenteral Segment

Figure 203 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Parenteral Segment

Figure 204 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Veterinary Hospitals Segment

Figure 205 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Veterinary Hospitals Segment

Figure 206 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Veterinary Clinics Segment

Figure 207 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Veterinary Clinics Segment

Figure 208 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Pharmacies Segment

Figure 209 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Pharmacies Segment

Figure 210 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Others Segment

Figure 211 : Japan Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others Segment

Figure 212 : Japan Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, By Causative Agent

Figure 213 : Japan Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, By Treatment Type Type

Figure 214 : Japan Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, by Route of Administration 

Figure 215 : Japan Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, by Distribution Channel

Figure 216 : MEA Swine Respiratory Diseases Treatment Market Value Share By Causative Agent (2017)

Figure 217 : MEA Swine Respiratory Diseases Treatment Market Value Share By Treatment Type (2017)

Figure 218 : MEA Swine Respiratory Diseases Treatment Market Value Share By Route of Administration (2017)

Figure 219 : MEA Swine Respiratory Diseases Treatment Market Value Share By Distribution Channel (2017)

Figure 220 : MEA Swine Respiratory Diseases Treatment Market Forecast 2017 and 2027

Figure 221 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 222 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 223 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Virus Segment

Figure 224 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Virus Segment

Figure 225 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Segment

Figure 226 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Segment

Figure 227 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Bacteria Segment

Figure 228 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Bacteria Segment

Figure 229 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Others Segment

Figure 230 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others Segment

Figure 231 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Drugs  Segment

Figure 232 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Drugs  Segment

Figure 233 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Vaccines Segment

Figure 234 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vaccines Segment

Figure 235 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Oral Segment

Figure 236 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Oral Segment

Figure 237 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Parenteral Segment

Figure 238 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Parenteral Segment

Figure 239 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Veterinary Hospitals Segment

Figure 240 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Veterinary Hospitals Segment

Figure 241 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Veterinary Clinics Segment

Figure 242 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Veterinary Clinics Segment

Figure 243 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Pharmacies Segment

Figure 244 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Pharmacies Segment

Figure 245 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) Analysis, 2012–2016, by Others Segment

Figure 246 : MEA Swine Respiratory Diseases Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Others Segment

Figure 247 : MEA Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, By Causative Agent

Figure 248 : MEA Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, By Treatment Type Type

Figure 249 : MEA Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, by Route of Administration 

Figure 250 : MEA Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, by Distribution Channel

Figure 251 : MEA Swine Respiratory Diseases Treatment Market Attractiveness Analysis, 2017–2027, by Country

Figure 252 : Global Swine Respiratory Diseases Treatment Market Attractiveness Analysis by Region, 2017–2027 

Figure 253 : Global Swine Respiratory Diseases Treatment Market Attractiveness Analysis By Causative Agent, 2017–2027 

Figure 254 : Global Swine Respiratory Diseases Treatment Market Attractiveness Analysis By Treatment Type, 2017–2027 

Figure 255 : Global Swine Respiratory Diseases Treatment Market Attractiveness Analysis by Route of Administration, 2017–2027 

Figure 256 : Global Swine Respiratory Diseases Treatment Market Attractiveness Analysis by Distribution Channel, 2017–2027 

Figure 257 : Global Swine Respiratory Diseases Treatment Market Value Analysis and Forecast, 2016–2027 (US$ Mn)

Figure 258 : Global Swine Respiratory Diseases Treatment Market Absolute $ Opportunity (US$ Mn), 2012–2016

Figure 259 : Global Swine Respiratory Diseases Treatment Market Absolute $ Opportunity (US$ Mn), 2016–2027

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Swine Respiratory Diseases Treatment Market